Literature DB >> 8537186

Determination of disulfide bridge pattern in omega-conopeptides.

D Chung1, S Gaur, J R Bell, J Ramachandran, L Nadasdi.   

Abstract

Synthetic versions of seven naturally occurring omega-conopeptides were subjected to structural analyses in order to determine their disulfide bridge pattern. The method applied in this study uses a combination of amino-acid composition and peptide sequence analysis of various peptide fragments generated by different enzymatic digestions. A temperature modification in the Edman degradation cycles of a protein sequencer allowed the unambiguous detection of the cleavage of cystine residues. The appearance of the cystine residues in particular cycles of the sequence analysis was characteristic of one or several of the theoretically possible 15 isomers. In the case of multiple choices, possible isomers were further eliminated by the amino-acid and sequence analysis of peptide fragments generated by the enzymatic digestion. All synthetic peptides, SNX-111, -157, -159, -183, -185, -230 and -231, were found to have the same disulfide bridge pattern as determined for the naturally occurring omega-conopeptide G-VI-A, i.e. disulfide bridges between the half-cystines 1-16, 8-20 and 15-25 (using the amino-acid numbering of SNX-111).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537186     DOI: 10.1111/j.1399-3011.1995.tb00604.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  9 in total

1.  Solution structure and backbone dynamics of an omega-conotoxin precursor.

Authors:  D P Goldenberg; R E Koehn; D E Gilbert; G Wagner
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

Review 2.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

3.  Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.

Authors:  Maciej Gasior; Natalie A White; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2007-08-23       Impact factor: 4.030

4.  Marine natural products: a way to new drugs.

Authors:  V A Stonik
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

Review 5.  Cyclic peptide drugs approved in the last two decades (2001-2021).

Authors:  Huiya Zhang; Shiyu Chen
Journal:  RSC Chem Biol       Date:  2021-11-05

6.  Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.

Authors:  Howard S Smith; Timothy R Deer
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

Review 7.  Venom peptides as a rich source of cav2.2 channel blockers.

Authors:  Silmara R Sousa; Irina Vetter; Richard J Lewis
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

8.  Ziconotide: a review of its pharmacology and use in the treatment of pain.

Authors:  Joseph G McGivern
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 9.  Omega-conotoxins as experimental tools and therapeutics in pain management.

Authors:  Heidi E Hannon; William D Atchison
Journal:  Mar Drugs       Date:  2013-03-07       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.